Seaport Therapeutics Said to Raise $255 Million in Upsized IPO

Seaport Therapeutics Inc., a clinical-stage biotechnology company focused on antidepressants and anxiety drugs, raised nearly $255 million in an upsized US initial public offering that priced at the top of its marketed range, according to people familiar with the matter.


www.bloomberg.com
#Seaport #Therapeutics #Raise #Million #Upsized #IPO